We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.
- Authors
Joensuu, Heikki; Bono, Petri; Kataja, Vesa; Alanko, Tuomo; Kokko, Riitta; Asola, Raija; Utriainen, Tapio; Turpeenniemi-Hujanen, Taina; Jyrkkiö, Sirkku; Möykkynen, Kari; Helle, Leena; Ingalsuo, Seija; Pajunen, Marjo; Huusko, Mauri; Salminen, Tapio; Auvinen, Päivi; Leinonen, Hannu; Leinonen, Mika; Isola, Jorma; Kellokumpu-Lehtinen, Pirkko-Liisa
- Abstract
Docetaxel has not been compared with vinorelbine as adjuvant treatment of early breast cancer. Efficacy and long-term safety of a short course of adjuvant trastuzumab administered concomitantly with chemotherapy for human epidermal growth factor receptor 2 (HER2) -positive cancer are unknown.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 34, p5685
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.21.4577